Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vi-CRM197 typhoid human challenge study
2011-003653-26Phase 2Terminated
- Sponsor
- Clinical Trials and Research Governance
- Start
- Dec 2011
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of TyphiBEV and salmonella typhi capsular polysaccharide vaccine in typhoid fever, sponsored by Clinical Trials and Research Governance. Primary endpoint: Proportion developing typhoid fever after challenge. Started Dec 2011; status: terminated.
02
Drugs
TyphiBEVsalmonella typhi capsular polysaccharide vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on 2011-003653-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003653-26.